Turning Point Therapeutics

When Turning Point Therapeutics hits the markets Wednesday, it wants to pivot your portfolio toward the rich field of oncology. The IPO Turning Point has priced 9.25 million shares at $18 per share on the Nasdaq under ticker "TPTX." The offering represents 30.2 percent of outstanding...

For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud. The IPO dates below are expected but not confirmed. Brainsway Ltd (BWAY) will issue 2.5 million shares at $11.94 Wednesday on the Nasdaq. The offering represents about 23.1 percent of outstanding shares and is expected...